Oguz Halit, Sobaci Gungor
Department of Ophthalmology, Harran University Medical School, Sanliurfa, Turkey.
Surv Ophthalmol. 2008 Mar-Apr;53(2):112-20. doi: 10.1016/j.survophthal.2007.12.002.
Hyperbaric oxygen therapy is a primary or adjuvant therapeutic method used in treatment of various acute or chronic disorders. Currently, eye diseases are among the off-label use of hyperbaric oxygen. However, there is an increasing body of evidence showing its safety and efficacy in retinal artery occlusion, cystoid macular edema secondary to retinal vein occlusion, scleral thinning and necrosis faced after pterygium surgery, orbital rhino-cerebral mucormycosis, nonhealing corneal edema, and anterior segment ischemia. Its potential to treat some blinding disease has also been pointed out in recent studies. This article constitutes an up-to-date summary of knowledge and therapeutic use of hyperbaric oxygen, and aims to contribute understanding of current and potential use of hyperbaric oxygen therapy in ophthalmology.
高压氧疗法是用于治疗各种急慢性疾病的主要或辅助治疗方法。目前,眼科疾病属于高压氧的非适应证使用。然而,越来越多的证据表明其在视网膜动脉阻塞、视网膜静脉阻塞继发的黄斑囊样水肿、翼状胬肉手术后面临的巩膜变薄和坏死、眼眶鼻脑毛霉菌病、不愈合的角膜水肿以及眼前段缺血等疾病中具有安全性和有效性。近期研究也指出了其治疗某些致盲性疾病的潜力。本文对高压氧的知识和治疗应用进行了最新总结,旨在促进对高压氧疗法在眼科当前及潜在应用的理解。